Science & academia

This archive covers milestones and breakthroughs from the scientific and academic world — researchers, universities, and institutions whose work advances human knowledge. Stories here highlight discoveries, studies, and scholarly efforts that point toward a better future.

Holding a nasal spray, for article on prehospital stroke nasal spray

Hong Kong researchers develop world-first nasal spray for stroke, cutting damage 80%

By / / Good News For Humankind

A nasal spray for stroke, developed at the University of Hong Kong, cut brain damage by more than 80% when given within 30 minutes of an ischemic stroke in preclinical studies. The idea is beautifully simple: tiny particles travel from the nose directly along nerve pathways to the brain, sidestepping the blood-brain barrier that derails most neurological drugs. Designed to be as easy to use as an EpiPen, it could let a bystander start protecting brain cells before the ambulance even arrives. Clinical trials are still years away, but if it holds up, this kind of “protection-first” thinking could reshape emergency care for stroke patients everywhere — especially the 85% who currently never reach treatment in time.

Supplement capsule, for article on vitamin D breast cancer study

Brazilian scientists find that vitamin D boosts breast cancer treatment success by 79%

By / / Good News For Humankind

Vitamin D may give breast cancer chemotherapy a meaningful boost, according to a new randomized trial in Brazil. Among 80 women undergoing chemo before surgery, those taking 2,000 IU of vitamin D daily saw their tumors completely disappear 43% of the time, compared with 24% in the placebo group. Researchers think the nutrient may act as a chemosensitizer, helping cancer cells respond more fully to treatment. The authors are careful to note that a trial this small isn’t the final word, and larger studies are needed before guidelines change. Still, the idea that something as simple, safe, and affordable as vitamin D could improve outcomes for the world’s most commonly diagnosed cancer is genuinely hopeful news worth watching.

Scientist filling tubes, for article on reversible male contraception

Cornell researchers achieve first reversible male birth control in mice

By / / Good News For Humankind

Reversible male birth control just cleared a major hurdle: in a new Cornell study, male mice stopped producing sperm entirely after three weeks of treatment, then bounced back to full fertility within six weeks of stopping. The approach skips hormones altogether, targeting a specific window of sperm development in the testis so libido and other traits stay untouched. Even better, the mice went on to father healthy pups who were themselves fertile. The researchers are now testing new molecular targets and hope to launch a company within two years to move toward human trials. If the science holds up across species, it could finally give men a real long-acting option — and ease a contraceptive burden women have shouldered alone for generations.

People holding breast cancer pin, for article on vitamin D breast cancer

Brazilian researchers find vitamin D boosts breast cancer chemo by 79%

By / / Good News For Humankind

Vitamin D may give breast cancer chemotherapy a meaningful boost, according to a new Brazilian trial in which 43% of women taking a daily supplement saw their tumors disappear completely, compared to 24% on a placebo. Researchers at São Paulo State University gave 80 patients a modest 2,000 IU dose alongside their standard pre-surgery chemo — a level safe enough for everyday use and cheap enough for almost anyone. Most women in the study were vitamin D-deficient to begin with, a pattern common in cancer patients worldwide. If larger trials confirm the finding, it points to something rare and hopeful in oncology: a low-cost, low-risk addition that could improve outcomes most for the communities currently facing the steepest deficiency rates and the hardest cancer journeys.

Medical researcher in a lab examining vials related to asthma and COPD treatment and mRNA vaccine development, for article on benralizumab injection, for article on mRNA lung cancer vaccine

Doctors hail first breakthrough in asthma and COPD treatment in 50 years

By / / Good News For Humankind

Benralizumab, a single injection given during an asthma or COPD attack, outperformed the steroid pills that have been the only emergency option since the 1970s. In a King’s College London trial of 158 patients, those who got the shot had four times fewer treatment failures over 90 days, along with easier breathing and fewer follow-up visits. Because steroids carry real risks with repeated use — diabetes, osteoporosis, and more — a genuine alternative could change daily life for millions of people who live in fear of the next flare-up. After a half-century of stalled progress on diseases that claim 3.8 million lives a year, this feels like the door finally opening.

Researcher examining brain scan imagery for an article about Alzheimer's prevention trial results

U.S. researchers cut Alzheimer’s risk by half in first-ever prevention trial

By / / Good News For Humankind

Alzheimer’s prevention may have reached a turning point after a landmark trial showed that removing amyloid plaques before symptoms appear can cut the risk of developing the disease by roughly 50%. Researchers at Washington University School of Medicine studied people with rare genetic mutations that make Alzheimer’s nearly inevitable, finding that early, aggressive treatment can genuinely alter the disease’s course. The results, published in The Lancet Neurology, mark the first time any intervention has shown potential to prevent Alzheimer’s from appearing at all, not merely slow its progression. That distinction matters enormously, since amyloid begins accumulating in the brain two decades before symptoms emerge.

A person sitting quietly on a bench at sunset, for an article about global suicide rate decline — 15 words.

Global suicide rate has dropped nearly 40% since the 1990s

By / / Good News For Humankind

Global suicide rates have dropped nearly 40% since the early 1990s, falling from roughly 15 deaths per 100,000 people to around nine — one of modern public health’s most significant and underreported victories. This decline was driven by expanded mental health services, crisis intervention programs, and proven strategies like restricting access to lethal means. The progress spans dozens of countries, with especially sharp declines in East Asia and Europe. Critically, this trend demonstrates that suicide is preventable at a population level — making the case for sustained investment in mental health infrastructure worldwide.

A researcher examining brain scan imaging for an article about Parkinson's stem cell treatment — 14 words.

Japan approves world’s first Parkinson’s stem cell treatment to restore brain function

By / / Good News For Humankind

Japan’s Parkinson’s stem cell treatment has reached a landmark milestone after the country approved the world’s first iPSC-based therapy for the disease, offering real hope to an estimated 10 million patients globally. Developed by researchers at Kyoto University, the treatment transplants lab-grown dopamine-producing neurons directly into patients’ brains to replace those destroyed by Parkinson’s. Unlike existing medications that only manage symptoms, this approach attempts to restore the underlying neural machinery. Early trials showed measurable improvements in motor function, and Japan’s conditional approval now opens a genuine clinical pathway that simply did not exist before.

A researcher examining a vial in a medical laboratory for an article about Type 1 diabetes cure research

Stanford researchers take a major step toward curing Type 1 diabetes

By / / Good News For Humankind

Type 1 diabetes cure research took a significant step forward as Stanford University scientists demonstrated a hybrid approach combining gene therapy and immune system retraining to protect insulin-producing beta cells. Rather than simply replacing destroyed cells, the method attempts to retrain the immune system to stop attacking them — targeting the root cause of the disease. In preclinical animal trials, the approach restored normal blood sugar regulation without requiring lifelong immunosuppressant drugs. For the millions living with this demanding, costly condition, the findings represent meaningful progress toward a functional cure.

A researcher examines cancer cells under a microscope for an article about pancreatic tumor regression — 14 words.

Spanish researchers achieve full pancreatic tumor regression in a mouse model study

By / / Good News For Humankind

Pancreatic tumor regression achieved in mice marks a rare and significant breakthrough in one of oncology’s most stubborn challenges. Researchers at Spain’s National Cancer Research Centre induced complete disappearance of established pancreatic tumors by reprogramming the tumor microenvironment, allowing the immune system to recognize and destroy cancer cells. Pancreatic cancer kills the vast majority of patients it affects, with a five-year survival rate below 12%, partly because dense tissue surrounding tumors blocks treatment and hides cancer from immune defenses. While mouse results don’t guarantee human success, this proof of concept signals that full regression in this disease is biologically possible.